Details for Patent: 10,844,058
✉ Email this page to a colleague
Which drugs does patent 10,844,058 protect, and when does it expire?
Patent 10,844,058 protects INGREZZA and is included in one NDA.
This patent has thirty-eight patent family members in thirty countries.
Summary for Patent: 10,844,058
Title: | Valbenazine salts and polymorphs thereof |
Abstract: | Provided herein are salts of (S)-2-amino-3-methyl-butyric acid (2R,3R,11bR)-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[- 2,l-a]isoquinolin-2-yl ester in amorphous and crystalline forms, and processes of preparation, and pharmaceutical compositions thereof. Also provided are methods of their use for treating, preventing, or ameliorating one or more symptoms of neurological disorders and diseases including hyperkinetic movement disorders or diseases. |
Inventor(s): | McGee; Kevin (San Diego, CA), Zook; Scott E. (San Diego, CA), Carr; Andrew (Cambridge, GB), Bonnaud; Thierry (Cambridge, GB), Li; Bin-Feng (Suzhou Industrial Park, CN) |
Assignee: | Neurocrine Biosciences, Inc. (San Diego, CA) |
Application Number: | 16/899,641 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; Dosage form; |
Drugs Protected by US Patent 10,844,058
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-001 | Apr 11, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-001 | Apr 11, 2017 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-003 | Apr 23, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-003 | Apr 23, 2021 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-002 | Oct 4, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | TREATMENT OF TARDIVE DYSKINESIA | ⤷ Try a Trial | ||
Neurocrine | INGREZZA | valbenazine tosylate | CAPSULE;ORAL | 209241-002 | Oct 4, 2017 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | A METHOD OF TREATING HUNTINGTON'S CHOREA | ⤷ Try a Trial | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,844,058
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Australia | 2016343633 | ⤷ Try a Trial | |||
Brazil | 112018008460 | ⤷ Try a Trial | |||
Canada | 3002074 | ⤷ Try a Trial | |||
Chile | 2018001089 | ⤷ Try a Trial | |||
China | 108473489 | ⤷ Try a Trial | |||
China | 115304596 | ⤷ Try a Trial | |||
China | 115322188 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |